Thyrocare Technologies Limited (NSE:THYROCARE)
India · Delayed Price · Currency is INR 1,320.80
-5.10 (-0.38%)
Aug 1, 2025, 3:30 PM IST
Paycor HCM Market Cap
Thyrocare Technologies has a market cap or net worth of 70.13 billion as of August 1, 2025. Its market cap has increased by 106.19% in one year.
Market Cap
70.13B
Enterprise Value
68.83B
Revenue
7.23B
Ranking
n/a
PE Ratio
65.99
Stock Price
$1,320.80
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 70.13B, an increase of 111.22%. That is a compound annual growth rate of 8.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 70.13B | 44.71% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | 48.30B | 67.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,159.97B |
| Divi's Laboratories | 1,772.40B |
| Cipla | 1,259.61B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,062.98B |
| Zydus Lifesciences | 1,001.35B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 636.20B |